With over a decade of operation, this CTD dossier owner and manufacturer focuses on expanding its manufacturing capabilities and celebrating milestones. It has recently upgraded its facilities with new equipment and is preparing for its 2024 Annual General Meeting (AGM). The company emphasizes its commitment to shareholder engagement and recent developments, including the induction of new team members and a major anniversary celebration. Their product range and specific therapeutic areas were not detailed, but the emphasis on operational advancements and shareholder communication highlights their dedication to growth and industry presence.